A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein.

A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein.

Here we report that the OX-TES-1 SEREX antigen, which showed immunological reactivity with serum from four out of 10 diffuse large B-cell lymphoma (DLBCL) patients, is encoded by a novel gene, PAS domain containing 1 (PASD1). PASD1_v1 cDNA encodes a 639 amino-acid (aa) protein product, while an alte...

Full description

Bibliographic Details
Main Authors:	Liggins, A, Brown, P, Asker, K, Pulford, K, Banham, A
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
by: Ait-Tahar, K, et al.
Published: (2009)

Serologic detection of diffuse large B-cell lymphoma-associated antigens.
by: Liggins, A, et al.
Published: (2004)

PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy.
by: Cooper, C, et al.
Published: (2006)

Erratum: Serologic detection of diffuse large B-cell lymphoma-associated antigens (International Journal of Cancer (2004) 110 (563-569))
by: Liggins, A, et al.
Published: (2004)

MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.
by: Liggins, A, et al.
Published: (2007)

Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.
by: Cooper, C, et al.
Published: (2011)

Identification of lymphoma-associated antigens using SEREX.
by: Liggins, A, et al.
Published: (2005)

A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies
by: Liggins, A, et al.
Published: (2010)

A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies.
by: Liggins, A, et al.
Published: (2010)

Cytotoxic T-cell response to the PASD1 protein in patients with diffuse large B-cell lymphoma
by: Ait-Tahar, K, et al.
Published: (2009)

Immunochemical studies of antigenic lymphoma-associated proteins.
by: Pulford, K, et al.
Published: (2002)

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
by: Lawrie, C, et al.
Published: (2008)

CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.
by: Ait-Tahar, K, et al.
Published: (2011)

Identification of Huntingtin Interacting Protein 1 Related (HIP1R) as a Novel Lymphoma Autoantigen Using Antigen Array Profiling
by: Wong, K, et al.
Published: (2008)

Identification of Huntingtin interacting protein 1 related (HIP1R) as a novel lymphoma autoantigen using antigen array profiling
by: Wong, K, et al.
Published: (2009)

The significance of FOXP1 in diffuse large B-cell lymphoma
by: Gascoyne, D, et al.
Published: (2016)

DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
by: Joseph-Pietras, D, et al.
Published: (2010)

Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies.
by: Campbell, A, et al.
Published: (2010)

Sp17 protein expression and major histocompatibility class I and II epitope presentation in diffuse large B cell lymphoma patients
by: Ait-Tahar, K, et al.
Published: (2017)

Frequency of antigens expression and epstein-barr virus on diffuse large b-cell lymphoma
by: Lee, K.K., et al.
Published: (2007)

Diffuse large B-cell lymphoma
by: Gatter, K, et al.
Published: (2010)

Identification of FOXP1 Transcriptional Targets in Diffuse Large B Cell Lymphoma
by: Camilleri, E, et al.
Published: (2012)

Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma.
by: Pulford, K, et al.
Published: (2000)

RNASET2--an autoantigen in anaplastic large cell lymphoma identified by protein array analysis.
by: Patel, S, et al.
Published: (2012)

RNASET2 - An autoantigen in anaplastic large cell lymphoma identified by protein array analysis
by: Patel, S, et al.
Published: (2012)

Pathway activation patterns in diffuse large B-cell lymphomas.
by: Bentink, S, et al.
Published: (2008)

Increased Expression of Phosphorylated FADD in Anaplastic Large Cell and Other T-Cell Lymphomas.
by: Patel, S, et al.
Published: (2014)

Candidate testis-determining gene, Maestro (Mro), encodes a novel HEAT repeat protein.
by: Smith, L, et al.
Published: (2003)

Functional analysis of cancer/testis antigens in human cancer
by: Pagotto, A
Published: (2013)

PASD1 is a potential multiple myeloma-associated antigen.
by: Sahota, S, et al.
Published: (2006)

Testis specific gene expression drives disease progression and Rituximab resistance in lymphoma.
by: Knapp, S
Published: (2013)

Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma
by: Ernst, M, et al.
Published: (2021)

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
by: Wong, K, et al.
Published: (2014)

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.
by: Wong, K, et al.
Published: (2014)

TRPM4 expression is associated with activated B-cell subtype and poor survival in diffuse large B-cell lymphoma
by: Loo, S, et al.
Published: (2017)

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
by: Banham, A, et al.
Published: (2005)

Conserved oncogenic module activation patterns (COMAPS) identify biologically homogeneous groups of diffuse large B-cell lymphomas and clearly define Burkitt lymphoma
by: Bentink, S, et al.
Published: (2008)

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.
by: Nyman, H, et al.
Published: (2009)

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
by: Barrans, S, et al.
Published: (2004)

Translocations involving IGH gene predict better survival in gastric diffuse large B-cell lymphoma
by: Ye, H, et al.
Published: (2008)